iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Q1FY24 Review: KIMS: Resilient performance in a seasonally weak quarter

9 Aug 2023 , 10:46 AM

KIMS’ Ebitda (pre Ind-AS) grew 18% YoY in Q1, 2% ahead of analysts of IIFL Securities estimates, driven by a robust 15% YoY revenue growth in KIMS’ Telangana/AP hospitals (ex-Sunshine, Nagpur). Despite its dominance in core markets, mgmt still sees opportunities to drive further growth in Telangana/AP cluster by adding Oncology/Mother & Childcare speciality across its hospitals and by adding 1,500 beds in these markets over the next 3-4 years. Additionally, KIMS’ expansion plans to add 1,350 beds in Bangalore, Nashik and Thane by H1FY25 will also help diversify presence across new markets. Scale-up in profitability of Sunshine, Nagpur and existing AP hospitals would enable KIMS to absorb the margin-drag from new hospitals. Hence, analysts of IIFL Securities expect Ebitda margins to largely hold steady at ~26% over the next 3 years. They forecast 18% Ebitda Cagr over FY23-26. Maintain BUY rating with a TP of Rs 2,150 (18% upside). 

Enough headroom to grow in Telangana/AP: 

KIMS’ IP volumes in existing hospitals (ex-Sunshine/Nagpur) grew 11% YoY in Q1 and analysts of IIFL Securities believe there is further scope to drive volume growth since the company intends to operate at 70-75% occupancies in these markets post addition of 1,500 beds as well over the next 3-4 years. While Ebitda margins in Telangana cluster at 31% in Q1 (vs 35% in Q4) were impacted by corporate overheads for expansion projects and Q1 seasonality, which should normalise, mgmt believes that margins in AP hospitals can improve to 25-27% vs 22% in Q1. 

Multiple levers of margin improvement in Sunshine/Nagpur over the next 2 years, driven by (a) Relocation of Sunshine to new Begumpet campus in Q2, which will enable KIMS to recruit additional doctors and improve occupancies from current levels of 44%. (b) 200-300bps margin improvement can accrue at Sunshine Gachibowli from insourcing of diagnostics business (c) 60-70% of new doctor onboarding at the Nagpur hospital will be completed over the next 3 quarters. KIMS believes Sunshine can clock 30% margins (vs 23% in Q1) driven by better case mix & improving occupancies, while Nagpur hospital can clock 25-27% margins (vs 6% in Q1) post expansion of the doctor team over the next 24 months. 

Capacity-addition plans well on track: 

2 new hospitals in Bangalore (750 beds) to be operationalised by H1FY25, Nashik hospital (300 beds) to be operationalised by Q4FY24/Q1FY25, and Thane hospital (300 beds) to be operationalised by Q2FY25. Analysts of IIFL Securities have assumed combined start-up Ebitda losses of Rs300mn from these 3 hospitals in FY25.

Related Tags

  • KIMS
  • KIMS q1
sidebar mobile


Read More

Most Read News

Indian markets close on a positive note
14 Jun 2024|06:41 PM
Sensex and Nifty Surge
14 Jun 2024|06:43 PM
LIC stock price up by more than 5% today
14 Jun 2024|06:44 PM
Read More
Knowledge Centerplus

Logo IIFL Customer Care Number
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Knowledge Centerplus

Follow us on


2024, IIFL Securities Ltd. All Rights Reserved

  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.